ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA

Clinical trials for ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to keep advanced bladder cancer at bay

Disease control Ongoing

This large, late-stage trial is testing if adding a pill called cabozantinib to an immunotherapy drug (avelumab) is better than the immunotherapy alone for keeping advanced bladder cancer from growing or returning. It is for patients whose cancer did not worsen after their first …

Matched conditions: ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA

Get alerted when new ADVANCED RENAL PELVIS UROTHELIAL CARCINOMA trials appear

New drug combo aims to keep advanced bladder cancer at bay